Founded in 2008, Seventh Sense Biosystems is developing an array of products based on the company's proprietary TAP™ (Touch Activated Phlebotomy) painless blood collection platform, with an initial focus on enabling important diagnostic testing at the point of care by reducing the discomfort, anxiety and hassle of blood sample collection. Seventh Sense is a Flagship VentureLabs™ company.

Harry Wilcox is on the Board of Directors.